GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Myod1 | mm39_v1_chr7_+_46025890_46025904 | 0.65 | 2.0e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_23629080 Show fit | 20.37 |
ENSMUST00000033947.15
|
ankyrin 1, erythroid |
|
chr8_+_23629046 Show fit | 15.54 |
ENSMUST00000121075.8
|
ankyrin 1, erythroid |
|
chr1_-_132318039 Show fit | 13.05 |
ENSMUST00000132435.2
|
transmembrane and coiled-coil domains 2 |
|
chr17_+_37180437 Show fit | 12.90 |
ENSMUST00000060524.11
|
tripartite motif-containing 10 |
|
chr7_-_142223662 Show fit | 10.51 |
ENSMUST00000228850.2
|
predicted gene, 49394 |
|
chr7_+_141995545 Show fit | 10.23 |
ENSMUST00000105971.8
ENSMUST00000145287.8 |
troponin I, skeletal, fast 2 |
|
chr6_-_125471666 Show fit | 9.83 |
ENSMUST00000032492.9
|
CD9 antigen |
|
chr7_+_126810780 Show fit | 9.71 |
ENSMUST00000032910.13
|
myosin light chain, phosphorylatable, fast skeletal muscle |
|
chr12_-_76756772 Show fit | 9.30 |
ENSMUST00000166101.2
|
spectrin beta, erythrocytic |
|
chr12_+_109425769 Show fit | 9.04 |
ENSMUST00000173812.2
|
delta like non-canonical Notch ligand 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 44.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.8 | 21.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 18.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.6 | 15.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 14.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 14.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.8 | 12.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 12.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 11.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
2.1 | 10.7 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 42.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 22.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.1 | 20.9 | GO:0005861 | troponin complex(GO:0005861) |
1.3 | 19.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 18.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 18.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.4 | 15.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 12.1 | GO:0016459 | myosin complex(GO:0016459) |
2.8 | 11.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
3.3 | 9.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 44.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
3.4 | 34.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.4 | 22.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 16.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.4 | 14.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 12.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 11.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 10.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 10.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 10.5 | GO:0005178 | integrin binding(GO:0005178) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 19.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 19.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 13.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 11.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 11.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 9.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 8.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 8.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 6.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 5.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 54.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 42.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 22.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 15.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 14.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 10.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 10.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 10.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.6 | 8.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 8.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |